Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Orgenesis adopts stem cells with MaSTherCell

Written by DS on in the category news with the tags .


The American company Orgenesis obtained MaSTherCell (Gosselies) for $24.6 million.
Enterpreneur Hugues Bultot’s MaSTherCell specializes in the production of stem cells for therapeutic purposes such as gene therapy, immunotherapy and regenerative medicine. Orgenesis runs its activities around cell therapy for diabetes (type I) by applying hepatocytes to diabetes patients. Those cells “teach” the liver how to produce insulin. Orgenesis could have produced the cells themselves, but it would have required a bigger investment than acquiring MasterCell. MasterCell started in 2011 as a spin-off from the French-speaking ULB. It employs 34 people. This take-over saw Orgenesis’  value to rise from $40 to $60–70 million.

Other Walloon companies that operate around stem cells are Promethera, focusing on liver diseases, Bone Therapeutics, focusing on fractures and Cardio3 BioSciences, focusing on cardiovascular diseases. In Flanders, stem cell company Tigenix is working on autoimmune, inflammatory and knee cartilage diseases.

Read more about: .

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

UGent Flanders.bio Turnstone Janssen GSK V-Bio Ventures Itera Life Science KU Leuven XpandInnovation Biowin

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.